ACADIA Pharmaceuticals Inc.


Wednesday Morning’s Market Insights: Linn Energy LLC (LINE), Lululemon Athletica inc. (LULU), ACADIA Pharmaceuticals Inc. (ACAD), Opko Health Inc. (OPK)

Linn Energy LLC (NASDAQ:LINE) is up 9% in pre-market trading after oil prices rose slightly this morning due to a weaker dollar, which …

ACADIA Pharmaceuticals Inc (ACAD) and Galena Biopharma Inc (GALE) Attract Analysts Following Positive FDA Panel and Phase 3 Results

Stocks in the biotech sector are notoriously volatile pending pending FDA approvals and new drug trials. Analysts weigh in on ACADIA Pharmaceuticals Inc.

Biotech Beat: Analysts Chime In On Valeant Pharmaceuticals Intl Inc (VRX), ACADIA Pharmaceuticals Inc. (ACAD)

Healthcare analysts were out this morning with research reports on Valeant Pharmaceuticals Intl Inc (NYSE:VRX) and ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD).

ACADIA Pharmaceuticals Inc. (ACAD) Meets the FDA: All Eyes on Nuplazid

Investors and analysts are focused on ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) this week as the company goes head to head with the Psychopharmacologic Drugs …

Analysts Weigh In On Two Rising Healthcare Stocks: Valeant Pharmaceuticals Intl Inc (VRX), ACADIA Pharmaceuticals Inc. (ACAD)

While most of the major sectors showed modest moves amid a choppy trading day on Wall Street, significant strength is visible among biotechnology stocks. Among …

Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2015

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous …

Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Announces FDA Advisory Committee Meeting to Review NUPLAZID™

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous …

Stock Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Appoints James R. Owen, M.D., as Senior Vice President, Clinical Development and Chief Medical Officer

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous …

Biotech Beat: Analysts Weigh In on Galena Biopharma Inc (GALE), ACADIA Pharmaceuticals Inc. (ACAD) and Inovio Pharmaceuticals Inc (INO)

Healthcare analysts weighed in today on cancer therapeutics firm Galena Biopharma Inc (NASDAQ:GALE), biopharmaceutical company ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), and immunotherapy company Inovio Pharmaceuticals Inc (NASDAQ:INO).

Company Update (NASDAQ:ACAD): ACADIA Pharmaceuticals Inc. Appoints Jim Daly to Board of Directors

ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD), a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts